EKF Diagnostics Holdings PLC – EKF – Trading update

EKF Diagnostics Holdings PLC – EKF – Trading update

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that strong trading in October, combined with expected orders for the remainder of the year, will result in full year performance ahead of market expectations, which have already been revised upwards several times this year.

 

A significantly improved trading in the core business in the final quarter, along with continued orders for the PrimeStore MTM COVID-19 sample collection device underpins the Board's confidence of a strong full year performance.

 

EKF now expects to deliver Group revenues and adjusted EBITDA for the year ending 31 December 2020 comfortably ahead of market consensus, with expectations currently set at £60m for revenues and adjusted EBITDA of £23m.

 

 

The persons responsible for arranging the release of this Announcement on behalf of the Company are Julian Baines, CEO, and Richard Evans, FD and COO respectively.

No Comments

Post a Comment